The oncology market represents a huge piece of the pharmaceutical industry and continues to grow at rapid pace. But how to develop product value has always been a question of concern.
This presentation by Josephine A. Sollano, Vice President, Health Economics And Outcomes Research And Medical Communications, Pfizer Oncology Business Unit touches on the key points on developing and defining value, it's relation to stakeholders needs and personalised medicine, as well as communicating value.
In this presentation you will learn:
- How to develop value
- What is personalised medicine and is it the way forward
- Potential impact of personalised medicine on healthcare spending
- How to engage payors
- Impact of Targeted Drug Development on HEOR Activities
- Communicating value